Improving vaccines by targeting antigens to dendritic cells
Details
Publication Year 2009-02-28,Volume 41,Issue #2,Page 61-66
Journal Title
EXPERIMENTAL AND MOLECULAR MEDICINE
Publication Type
Journal Article
Abstract
A new approach to enhancing the effectiveness of vaccines is to deliver antigens selectively to dendritic cells (DC) in situ, via monoclonal antibodies specific for particular DC surface molecules. This can markedly enhance CTL responses and, via helper T cells, also enhance antibody responses. DC activation agents or adjuvants must also be administered for effective CTL responses, but in some cases good antibody responses can be obtained without adjuvants. Here we review the role of different DC subsets and different DC target molecules in obtaining enhanced immune responses.
Publisher
KOREAN SOC MED BIOCHEMISTRY MOLECULAR BIOLOGY
Keywords
SUBSETS IN-VIVO; C-TYPE LECTIN; STEADY-STATE; T-CELLS; CROSS-PRESENTATION; IFN-GAMMA; CD8(+); RESPONSES; IMMUNITY; CD4
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2009-02-28 12:00:00
An error has occurred. This application may no longer respond until reloaded. Reload 🗙